tiprankstipranks
Trending News
More News >

Roy Geoffrey Sargent Insider Profile

4 Followers
Roy Geoffrey Sargent, Chief Scientific Officer at GeneTether Therapeutics, Inc., holds 775.00K shares in GeneTether Therapeutics, Inc. (Ticker: TSE:RIZE). Most recently, Roy Geoffrey Sargent ― shares of GeneTether Therapeutics, Inc. on ― for an estimated value of ―.
tipranks
Roy Geoffrey Sargent

Roy Geoffrey Sargent
GeneTether Therapeutics, Inc. (RIZE)
Chief Scientific Officer

Not Ranked
Roy Geoffrey Sargent has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Roy Geoffrey Sargent does not currently own shares as a corporate insider.
A breakdown of Roy Geoffrey Sargent's holdings

Insider Roles

Roy Geoffrey Sargent does not currently hold a role as a corporate insider.
Roles that Roy Geoffrey Sargent holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Roy Geoffrey Sargent

Roy Geoffrey Sargent's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RIZE
GeneTether Therapeutics, Inc.
C$23.25K
TSE:RIZE
is no longer traded
Roy Geoffrey Sargent has not reported any informative transactions for TSE:RIZE, therefore, performance cannot be measured.
List of latest transactions for each holding click on a transaction to see Roy Geoffrey Sargent's performance on stock

Roy Geoffrey Sargent insider profile FAQ

What is the percentage of profitable transactions made by Roy Geoffrey Sargent?
The percentage of profitable transactions made by Roy Geoffrey Sargent is ―.
    What is the average return per transaction made by Roy Geoffrey Sargent?
    The average return per transaction made by Roy Geoffrey Sargent is ―.
      What stocks does Roy Geoffrey Sargent hold?
      Roy Geoffrey Sargent holds: TSE:RIZE stocks.
        What was Roy Geoffrey Sargent’s latest transaction?
        Roy Geoffrey Sargent latest transaction was an Uninformative Buy of ―.
          What was Roy Geoffrey Sargent's most profitable transaction?
          Roy Geoffrey Sargent’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Roy Geoffrey Sargent's role in GeneTether Therapeutics, Inc.?
            Roy Geoffrey Sargent's role in GeneTether Therapeutics, Inc. is Chief Scientific Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.